NCT07543224: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

Sponsor: Reistone Biopharma Company Limited. Phase: PHASE3. Conditions: Plaque Psoriasis Subjects